drugset / Trial / NCT02705014

Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome

NCT02705014

NaSingle-groupOpen-labelTreatment

Summary

To investigate the hormone response of hypothalamic-pituitary-gonad axis and spermatogenesis in male pituitary stalk interruption syndrome patients by pulsatile GnRH therapy.

Timeline

Start
2016-01
Primary completion
2016-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonadorelin Protein / enzyme biologic 10 ug Subcutaneous